-
Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1.
J Virol. 2001 Jun;75(11):5381-4
PMID: 11333921
-
Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents.
J Virol. 2001 May;75(10):4482-9
PMID: 11312318
-
Investigating the tolerance of coiled-coil peptides to nonheptad sequence inserts.
J Struct Biol. 2002 Jan-Feb;137(1-2):73-81
PMID: 12064935
-
The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block.
J Virol. 2002 Oct;76(19):10030-7
PMID: 12208981
-
The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells.
J Virol. 2002 Dec;76(24):12543-52
PMID: 12438580
-
CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
J Virol. 2003 Jan;77(2):1481-500
PMID: 12502863
-
bZIP proteins of human gammaherpesviruses.
J Gen Virol. 2003 Aug;84(Pt 8):1941-9
PMID: 12867624
-
Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.
EMBO J. 1989 Jan;8(1):127-32
PMID: 2540954
-
The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.
J Virol. 1989 Jul;63(7):3109-16
PMID: 2542618
-
The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.
EMBO J. 1989 May;8(5):1447-53
PMID: 2548844
-
The switch between EBV latency and replication.
Yale J Biol Med. 1989 Mar-Apr;62(2):205-13
PMID: 2549738
-
Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1.
J Virol. 1990 Mar;64(3):1227-32
PMID: 2154606
-
Structure and function of the Epstein-Barr virus BZLF1 protein.
J Virol. 1990 May;64(5):2110-6
PMID: 2157874
-
In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein.
J Virol. 1990 Jun;64(6):2560-8
PMID: 2159531
-
The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.
J Virol. 1990 Jul;64(7):3358-69
PMID: 2161945
-
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
Nucleic Acids Res. 1990 Jun 25;18(12):3587-96
PMID: 2194165
-
Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.
Proc Natl Acad Sci U S A. 1990 Dec;87(23):9459-63
PMID: 2174563
-
The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper.
Oncogene. 1991 Feb;6(2):195-204
PMID: 1847997
-
Predicting coiled coils from protein sequences.
Science. 1991 May 24;252(5009):1162-4
PMID: 2031185
-
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia.
J Virol. 1991 Jun;65(6):2868-74
PMID: 1851858
-
ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
J Virol. 1991 Aug;65(8):4033-41
PMID: 1649314
-
Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.
J Virol. 1992 Aug;66(8):4803-13
PMID: 1321270
-
Epstein-Barr virus transcription factors.
Cell Growth Differ. 1992 Aug;3(8):557-63
PMID: 1327084
-
The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.
EMBO J. 1996 Jun 3;15(11):2748-59
PMID: 8654372
-
G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta.
J Biol Chem. 1996 Dec 13;271(50):31799-802
PMID: 8943219
-
Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.
Trends Microbiol. 1997 Oct;5(10):399-405
PMID: 9351176
-
A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding.
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12274-9
PMID: 9356439
-
Sequence-based design of a peptide probe for the APC tumor suppressor protein.
Curr Biol. 1998 Jul 2;8(14):823-30
PMID: 9663391
-
The control of lytic replication of Epstein-Barr virus in B lymphocytes (Review).
Int J Mol Med. 1998 Jan;1(1):137-42
PMID: 9852211
-
Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target.
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15613-7
PMID: 9861018
-
Uncoiling c-Jun coiled coils: inhibitory effects of truncated Fos peptides on Jun dimerization and DNA binding in vitro.
Biopolymers. 1998;47(4):277-83
PMID: 10036969
-
Biology and disease associations of Epstein-Barr virus.
Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):461-73
PMID: 11313005
-
Dimerization of the Epstein-Barr virus ZEBRA protein in the yeast two-hybrid system. Comparison Of a ZEBRA variant with the B95-8 form.
Biochimie. 2000 Feb;82(2):139-45
PMID: 10727769
-
The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.
EMBO J. 2000 Jun 15;19(12):3080-9
PMID: 10856251
-
Herpesvirus lytic replication and the cell cycle: arresting new developments.
J Virol. 2001 May;75(10):4475-81
PMID: 11312317
-
Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.
Virology. 2001 Jun 5;284(2):159-69
PMID: 11384216